MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03851cam a22003377i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
17987152 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20210524124524.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
140103s2014 ne b 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2014000085 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780123969835 (hardback) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0123969832 (hardback) |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| Language of cataloging |
eng |
| Transcribing agency |
DLC |
| Description conventions |
rda |
| Modifying agency |
DLC |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
TP248.65.P62 |
| Item number |
N38 2014 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
610.28 KUM-S |
| Edition number |
23 |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Kumbar, Sangamesh |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Natural and synthetic biomedical polymers / |
| Statement of responsibility, etc. |
edited by Sangamesh G. Kumbar, Cato T. Laurencin, Meng Deng. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
First edition. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
New York |
| Name of publisher, distributor, etc. |
Elsevier |
| Date of publication, distribution, etc. |
2014 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xvii, 402 pages ; |
| Dimensions |
29 cm |
| 365 ## - TRADE PRICE |
|---|
| Price type code |
USD |
| Price amount |
130.00 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Machine generated contents note: Section 1. Synthesis and Characterization 1.1. Polymer Synthesis: the design and synthesis of important classes of polymeric biomaterials involving different monomers will be discussed. 1.2. Characterization of Polymeric Biomaterials: in vitro and in vivo characterization of advanced biomaterials, (cell and tissue interactions with polymeric biomaterials with various physico-chemical, mechanical properties, surface and degradation properties Section 2. Currently Used Materials 2.1. Proteins and poly(amino acids) including collagen, poly(amino acids), elastin and elastin-like polypeptides, albumin, and fibrin 2.2. Polysaccharides including hyaluronic acid, chondroitin sulfate, chitin and chitosan, and alginic acid 2.3. Poly(a-ester)s including polylactides, polyglycolide, poly(lactide-co-glycolide), polycaprolactone, and bacterial polyesters 2.4. Polyurethanes 2.5. Poly(ester amide) 2.6. Poly(ortho esters) 2.7. Polyanhydrides 2.8. Poly(propylene fumarate) 2.9. Polyphosphazenes 2.10. Pseudo poly(amino acid)s 2.11. Polyphosphoester 2.12. Polyacetals 2.13. Poly(ethylene glycol)-based biomaterials 2.14. Dendrimers 2.15. Elastomers Section 3. Biomedical Applications of Polymeric Biomaterials 3.1. Polymeric Biomaterials in Biomedical Implants 3.2. Polymeric Biomaterials in Drug Delivery 3.3. Polymeric Biomaterials in Tissue Engineering 3.4. Polymeric Biomaterials in Medical Diagnostics . |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
"Polymer scientists have made an extensive research for the development of biodegradable polymers which could find enormous applications in the area of medical science. Today, various biopolymers have been prepared and utilized in different biomedical applications. Despite the apparent proliferation of biopolymers in medical science, the Science and Technology of biopolymers is still in its early stages of development. Tremendous opportunities exist and will continue to exist for the penetration of biopolymers in every facet of medical science through intensive Research and Development. Therefore, this chapter addresses different polymerization methods and techniques employed for the preparation of biopolymers. An emphasis is given to cover the general properties of biopolymers, synthetic protocols and their biomedical applications. In order to make the useful biomedical devices from the polymers to meet the demands of medical science, various processing techniques employed for the development of devices have been discussed. Further, perspectives in this field have been highlighted and at the end arrived at the conclusions. The relevant literature was collected from different sources including Google sites, books and reviews"-- |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Biopolymers. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Biodegradable plastics. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Kumbar, Sangamesh, |
| Relator term |
editor of compilation. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Laurencin, Cato, |
| Relator term |
editor of compilation. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Deng, Meng, |
| Relator term |
editor of compilation. |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
|---|
| a |
7 |
| b |
cbc |
| c |
orignew |
| d |
1 |
| e |
ecip |
| f |
20 |
| g |
y-gencatlg |
| 955 ## - COPY-LEVEL INFORMATION (RLIN) |
|---|
| Book number/undivided call number, CCAL (RLIN) |
rl07 2014-01-03 |
| Copy status, CST (RLIN) |
rl07 2014-01-08 to Dewey |
| Classification number, CCAL (RLIN) |
xn09 2014-04-28 1 copy rec'd., to CIP ver. |
| 952 ## - LOCATION AND ITEM INFORMATION (KOHA) |
|---|
| Withdrawn status |
|
